The Wall Street Transcript Publishes Management Performance Review Investment Opinion on Applied Biosystems in Medical Technology and Devices Issue

Business Wire,  Dec 5, 2000  

• E-mail
• Print
• Link

Business Editors

NOTE: This interview is presented with the aforementioned

company's full knowledge and permission.

NEW YORK--(BUSINESS WIRE)--Dec. 5, 2000

Six leading analysts and top management from thirty-three sector firms examine the outlook for Medical Technology & Devices companies in this special 168-page issue from The Wall Street Transcript (212/952-7433) or http://www.twst.com/info/info230.htm

1) The TWST confidential Off-The-Record survey of management

performance at twenty-eight sector firms asked market insiders

about the ability of management teams to create shareholder

value.

Read a free interview highlight from this TWST Off-The-Record

report, in which an expert explains why a sector firm's

management team is considered "the worst in the industry. They

took a very predictable company and made it completely

unpredictable." See

http://twst.com/notes/articles/lag700a.html

An expert reports on Applied Biosystems, formerly PE

Biosystems (NYSE:ABI), "PE Biosystems continues to do very

well with sales and earnings growth well over 20%. The company

generates a lot of cash. It is the overwhelming leader in

things like DNA sequencing and some mass spectrometry markets.

From an investor perspective, this would be the first stock

you would own."

This 168-page special issue also features:

2) Medical Technology & Devices (13,700 words): Analyst

Roundtable with Mariola Haggar, President at Haggar Concord

Partners, Bruce Jacobs, Vice President at Deutsche Banc Alex.

Brown, Anne Malone, Vice President at Salomon Smith Barney,

and Frederick Wise, Senior Managing Director at Bear Stearns &

Company.

3) Medical Supplies & Devices (6,100 words): Analyst Interview

with David Gruber, Senior Vice President at Lehman Brothers.

4) Drug & Medical Device Stocks (4,000 words): Analyst Interview

with Samuel Gerszonowicz, Director at HCFP/Brenner Securities.

5) CEO interviews (average 2,500 words). Top management of

thirty-three sector firms examine the outlook for their firm

and the sector.

To obtain a copy of this 168-page Medical Technology and Devices issue, call 212/952-7433 or see http://www.twst.com/info/info230.htm

The Wall Street Transcript is a premier weekly investment publication interviewing market professionals for serious investors for over 37 years.

The Wall Street Transcript has launched a new free service where investors can ask the above company (or any public company) a question at http://www.qawire.com

The Wall Street Transcript does not endorse the views of any interviewee nor does it make stock recommendations.

COPYRIGHT 2000 Business Wire
COPYRIGHT 2008 Gale, Cengage Learning